On August 9 2024, Granules India Limited announced that it had received approval from the US Food & Drug Administration (US FDA) for its generic version of Trazodone Hydrochloride Tablets USP in 50 mg, 100 mg, 150 mg, and 300 mg doses. Trazodone tablets are bioequivalent and therapeutically equivalent to the reference drug Desyrel Tablets …